Clinical Trial Update: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating treatment of high-risk prostate cancer guided by novel diagnostic radio- and molecular tracers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Cancer Research Antwerp | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: RECRUITING